Clinical Trial Update: An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

This clinical trial update reports enrollment for an open-label extension study of subcutaneous zilucoplan in pediatric participants with generalized myasthenia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Zilucoplan (zilucoplan)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: ENROLLING_BY_INVITATION